Importantly, we have found a new molecular mechanism that promotes osteosarcoma cell growth and provided preclinical evidence for the CDK11p110-mediated CBFβ pathway as a molecular marker to predict osteosarcoma metastasis risk. This evidence concerns the gene CBFB and osteosarcoma.